Moody’s affirms ‘A2’ rating for MedStar Health

Moody’s Investors Service affirmed its “A2” rating on Columbia, Md.-based MedStar Health, affecting $1.4 billion of debt.

Advertisement

The affirmation reflects MedStar’s diversified clinical delivery network, which Moody’s believes will translate to further enterprise growth and strengthen the system’s market position.

The rating outlook remains stable.

More articles on healthcare finance:

SLU physician group implements hiring freeze after EHR rollout
Private equity pushes into healthcare: 6 latest deals
Oklahoma hospital to close in 2019

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.